These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33323922)

  • 1. [Impact of the inclusion of second-tier tests in the newborn screening program of Catalonia and in other international programs.].
    Pajares García S; López Galera RM; Marín Soria JL; Argudo Ramírez A; González de Aledo-Castillo JM; Ribes Rubió A; Prats Viedma B; Asso Ministral L; García-Villoria J
    Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33323922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
    Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
    Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of a second-tier test panel in dried blood spot samples using liquid chromatography-tandem mass spectrometry in Catalonia's newborn screening programme.
    Pajares-García S; González de Aledo-Castillo JM; Flores-Jiménez JE; Collado T; Pérez J; Paredes-Fuentes AJ; Argudo-Ramírez A; López-Galera RM; Prats B; García-Villoria J
    Clin Chem Lab Med; 2024 Feb; 62(3):493-505. PubMed ID: 37794778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests.
    la Marca G; Malvagia S; Casetta B; Pasquini E; Donati MA; Zammarchi E
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S395-404. PubMed ID: 18956250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of second-tier testing on the effectiveness of newborn screening.
    Chace DH; Hannon WH
    Clin Chem; 2010 Nov; 56(11):1653-5. PubMed ID: 20837783
    [No Abstract]   [Full Text] [Related]  

  • 6. Incorporation of second-tier tests and secondary biomarkers to improve positive predictive value (PPV) rate in newborn metabolic screening program.
    Younesi S; Yazdani B; Taheri Amin MM; Saadati P; Jamali S; Modarresi MH; Savad S; Amidi S; Razavi H; Ghafouri-Fard S
    J Clin Lab Anal; 2022 Jul; 36(7):e24471. PubMed ID: 35500172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation and perspective of 20 years of neonatal screening in Galicia. Program results.].
    Sánchez Pintos P; Cocho de Juan JÁ; Bóveda Fontán MD; Castiñeiras Ramos DE; Colón Mejeras C; Iglesias Rodríguez AJ; de Castro López MJ; Alonso Fernández JR; Fraga Bermúdez JM; Couce Pico ML
    Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33323918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry.
    la Marca G; Giocaliere E; Malvagia S; Funghini S; Ombrone D; Della Bona ML; Canessa C; Lippi F; Romano F; Guerrini R; Resti M; Azzari C
    J Pharm Biomed Anal; 2014 Jan; 88():201-6. PubMed ID: 24076575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tandem mass spectrometry as screening for inborn errors of metabolism].
    Campos H D
    Rev Med Chil; 2011 Oct; 139(10):1356-64. PubMed ID: 22286738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria.
    Shigematsu Y; Hata I; Tajima G
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S283-8. PubMed ID: 20440648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): An 8 year journey from pilot to current program.
    Lim JS; Tan ES; John CM; Poh S; Yeo SJ; Ang JS; Adakalaisamy P; Rozalli RA; Hart C; Tan ET; Ranieri E; Rajadurai VS; Cleary MA; Goh DL
    Mol Genet Metab; 2014; 113(1-2):53-61. PubMed ID: 25102806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The national Austrian newborn screening program - eight years experience with mass spectrometry. past, present, and future goals.
    Kasper DC; Ratschmann R; Metz TF; Mechtler TP; Möslinger D; Konstantopoulou V; Item CB; Pollak A; Herkner KR
    Wien Klin Wochenschr; 2010 Nov; 122(21-22):607-13. PubMed ID: 20938748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of mass spectrometry in newborn screening: about both small molecular diseases and lysosomal storage diseases.
    Hwu WL; Chien YH; Lee NC; Wang SF; Chiang SC; Hsu LW
    Top Curr Chem; 2014; 336():177-96. PubMed ID: 22911488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007).
    Matern D; Tortorelli S; Oglesbee D; Gavrilov D; Rinaldo P
    J Inherit Metab Dis; 2007 Aug; 30(4):585-92. PubMed ID: 17643193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of 2-methylcitric acid in dried blood spots improves newborn screening for propionic and methylmalonic acidemias.
    Al-Dirbashi OY; McIntosh N; Chakraborty P
    J Med Screen; 2017 Jun; 24(2):58-61. PubMed ID: 27216769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry.
    la Marca G; Malvagia S; Pasquini E; Innocenti M; Donati MA; Zammarchi E
    Clin Chem; 2007 Jul; 53(7):1364-9. PubMed ID: 17510301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded newborn screening by mass spectrometry: New tests, future perspectives.
    Ombrone D; Giocaliere E; Forni G; Malvagia S; la Marca G
    Mass Spectrom Rev; 2016; 35(1):71-84. PubMed ID: 25952022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
    Sarafoglou K; Gaviglio A; Hietala A; Frogner G; Banks K; McCann M; Thomas W
    J Pediatr; 2014 May; 164(5):1136-40. PubMed ID: 24582106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [First universal newborn screening program for severe combined immunodeficiency in Europe. Three-years' experience in Catalonia.].
    Argudo Ramírez A; Martín Nalda A; Marín Soria JL; López Galera RM; González de Aledo Castillo JM; Pajares García S; Rivière JG; Martínez Gallo M; Colobran R; Parra Martínez A; Ribes Rubio A; Fernández Bardon RM; Asso Ministral L; Prats Viedma B; García Villoria J; Soler Palacín P
    Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33323927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.